The U.S. Meals and Drug Administration has permitted GSK’s autoinjector of Benlysta (belimumab) for subcutaneous injection in sufferers ≥5 years…
Read More
The U.S. Meals and Drug Administration has permitted GSK’s autoinjector of Benlysta (belimumab) for subcutaneous injection in sufferers ≥5 years…
Read More
